(VIANEWS) – Universal Stainless & Alloy Products (USAP), Steven Madden, Ltd. (SHOO), Amphastar Pharmaceuticals (AMPH) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Universal Stainless & Alloy Products (USAP)
16.6% sales growth and 4.25% return on equity
Universal Stainless & Alloy Products, Inc., together with its subsidiaries, manufactures and markets semi-finished and finished specialty steel products in the United States and internationally. Its products include stainless steel, nickel alloys, tool steel, and various other alloyed steels. The company offers semi-finished and finished long products in the form of ingots, blooms, billets, and bars; flat rolled products, such as slabs and plates; and customized shapes primarily for original equipment manufacturers (OEMs), which are cold rolled from purchased coiled strip, flat bar, or extruded bar. Its semi-finished long products are primarily used to produce rods; and finished bar products that are principally used by OEMs and by service center customers for distribution to various end users. The company also offers conversion services on materials supplied by its customers. Its products are used in aerospace, power generation, oil and gas, heavy equipment, general, and automotive industries, as well as in the manufacturing of equipment for food handling, health and medical, chemical processing, and pollution control; and manufacturing of metals, plastics, paper and aluminum extrusions, pharmaceuticals, electronics, and optics. The company sells its products to service centers, forgers, rerollers, and OEMs. Universal Stainless & Alloy Products, Inc. was founded in 1994 and is headquartered in Bridgeville, Pennsylvania.
Earnings Per Share
As for profitability, Universal Stainless & Alloy Products has a trailing twelve months EPS of $1.02.
PE Ratio
Universal Stainless & Alloy Products has a trailing twelve months price to earnings ratio of 32.26. Meaning, the purchaser of the share is investing $32.26 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.25%.
2. Steven Madden, Ltd. (SHOO)
10.6% sales growth and 21.62% return on equity
Steven Madden, Ltd. designs, sources, markets, and sells fashion-forward branded and private label footwear, accessories, and apparel for women, men, and children in the United States and internationally. Its Wholesale Footwear segment provides footwear under the Steve Madden, Steven by Steve Madden, Madden Girl, BB Dakota, Dolce Vita, DV Dolce Vita, Betsey Johnson, GREATS, Blondo, Anne Klein, Mad Love, Superga, Madden NYC, and COOL Planet brands, as well as private label footwear. The company's Wholesale Accessories/Apparel segment offers handbags, apparel, small leather goods, belts, soft accessories, fashion scarves, wraps, gifting, and other accessories under the Steve Madden, BB Dakota, Anne Klein, Betsey Johnson, Cejon, Madden NYC, and Dolce Vita brands, as well as private label handbag and accessories to department stores, mass merchants, off-price retailers, online retailers, specialty stores, and independent stores. Its Direct-to-Consumer segment operates Steve Madden and Superga full-price retail stores, Steve Madden outlet stores, and Steve Madden shop-in-shops, as well as digital e-commerce websites, including SteveMadden.com, DolceVita.com, betseyjohnson.com, Blondo.com, GREATS.com, and Superga-USA.com. The company's Licensing segment licenses its Steve Madden, Madden Girl, and Betsey Johnson trademarks. Its First Cost segment operates as a buying agent for footwear products under private labels for national chains, specialty retailers, and value-priced retailers. As of December 31, 2021, it owned and operated 214 brick-and-mortar retail stores that included 147 Steve Madden full-price stores, 66 Steve Madden outlet stores, and 1 Superga store, as well as 6 e-commerce websites. Steven Madden, Ltd. was incorporated in 1990 and is headquartered in Long Island City, New York.
Earnings Per Share
As for profitability, Steven Madden, Ltd. has a trailing twelve months EPS of $2.42.
PE Ratio
Steven Madden, Ltd. has a trailing twelve months price to earnings ratio of 18.26. Meaning, the purchaser of the share is investing $18.26 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.62%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 12.8% and 4.5%, respectively.
Volume
Today’s last reported volume for Steven Madden, Ltd. is 706817 which is 7.99% above its average volume of 654506.
3. Amphastar Pharmaceuticals (AMPH)
9.7% sales growth and 25.34% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $2.91.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 14.15. Meaning, the purchaser of the share is investing $14.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.34%.
Yearly Top and Bottom Value
Amphastar Pharmaceuticals’s stock is valued at $41.19 at 06:22 EST, way below its 52-week high of $67.66 and way higher than its 52-week low of $36.56.
Moving Average
Amphastar Pharmaceuticals’s value is above its 50-day moving average of $40.64 and way below its 200-day moving average of $47.75.
Volume
Today’s last reported volume for Amphastar Pharmaceuticals is 344288 which is 6.11% below its average volume of 366708.
4. Core Laboratories N.V. (CLB)
8.9% sales growth and 17.4% return on equity
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products; and proprietary and joint industry studies. The Production Enhancement segment offers services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amstelveen, the Netherlands.
Earnings Per Share
As for profitability, Core Laboratories N.V. has a trailing twelve months EPS of $0.79.
PE Ratio
Core Laboratories N.V. has a trailing twelve months price to earnings ratio of 28.99. Meaning, the purchaser of the share is investing $28.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.4%.
5. Verra Mobility Corporation (VRRM)
8.2% sales growth and 23.78% return on equity
Verra Mobility Corporation provides smart mobility technology solutions and services in the United States, Canada, and Europe. It operates through two segments, Government Solutions and Commercial Services. The Government Solutions segment offers automated safety solutions, including services and technologies that enable photo enforcement through road safety camera programs, which detects and process traffic violations related to red light, speed, school bus, and city bus lanes. This segment serves municipalities, counties, school districts, and law enforcement agencies. The Commercial Services segment provides automated toll and violations management, and title and registration solutions to rental car companies, fleet management companies, and other large fleet owners. The company is headquartered in Mesa, Arizona.
Earnings Per Share
As for profitability, Verra Mobility Corporation has a trailing twelve months EPS of $0.5.
PE Ratio
Verra Mobility Corporation has a trailing twelve months price to earnings ratio of 59.44. Meaning, the purchaser of the share is investing $59.44 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.78%.
Moving Average
Verra Mobility Corporation’s worth is above its 50-day moving average of $27.25 and way higher than its 200-day moving average of $23.60.
Sales Growth
Verra Mobility Corporation’s sales growth is 7.8% for the ongoing quarter and 8.2% for the next.
Volume
Today’s last reported volume for Verra Mobility Corporation is 1036340 which is 2.78% below its average volume of 1066060.
6. Commerce Bancshares (CBSH)
6.9% sales growth and 16.81% return on equity
Commerce Bancshares, Inc. operates as the bank holding company for Commerce Bank that provides retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals and businesses in the United States. It operates through three segments: Consumer, Commercial, and Wealth. The Consumer segment offers various banking products and services, including consumer deposits; consumer loans, such as automobile, motorcycle, marine, tractor/trailer, recreational vehicle, fixed rate and revolving home equity, and other consumer loans; patient health care financing; real estate loans; indirect and other consumer financing; personal mortgage banking; consumer installment lending; and consumer debit and credit bank cards. The Commercial segment provides corporate lending, leasing, international, merchant and commercial bank card, and securities safekeeping and bond accounting services; and business products, government deposits, and related commercial cash management services, as well as sells fixed income securities to correspondent banks, corporations, public institutions, municipalities, and individuals. The Wealth segment provides traditional trust and estate planning, advisory and discretionary investment portfolio management, and brokerage services, as well as private banking accounts. The company also offers private equity investment, securities brokerage, insurance agency, specialty lending, and leasing services, as well as online and mobile banking services. It operates through a network of 287 locations in Missouri, Kansas, Illinois, Oklahoma, and Colorado, as well as commercial offices. Commerce Bancshares, Inc. was founded in 1865 and is headquartered in Kansas City, Missouri.
Earnings Per Share
As for profitability, Commerce Bancshares has a trailing twelve months EPS of $3.69.
PE Ratio
Commerce Bancshares has a trailing twelve months price to earnings ratio of 17.41. Meaning, the purchaser of the share is investing $17.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.81%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.6%, now sitting on 1.58B for the twelve trailing months.
Yearly Top and Bottom Value
Commerce Bancshares’s stock is valued at $64.24 at 06:22 EST, below its 52-week high of $65.38 and way higher than its 52-week low of $42.96.
Moving Average
Commerce Bancshares’s value is way above its 50-day moving average of $56.33 and way above its 200-day moving average of $52.69.
Volume
Today’s last reported volume for Commerce Bancshares is 806142 which is 55.49% above its average volume of 518439.
